Intrinsiqs

Is Vanda Pharmaceuticals Inc. overvalued?

Vanda Pharmaceuticals Inc. (VNDA) — key valuation metrics and fundamentals.

No verdict
Price
$5.03
Fair value
—
Current P/E
—
Normal P/E
33.5
Market cap
$302.5M
Dividend yield
0.0%
Return on equity
-85.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares VNDA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated